The Balochistan government has introduced free treatment for breast cancer, Hemophilia A, Multiple Sclerosis, and Juvenile ...
The Ministry of Health and Population and the World Federation of Hemophilia have signed an agreement to provide free medication to patients with hemophilia, a genetic disorder that causes blood ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 14 February 2025, approved efanesoctocog alfa (brand name Altuvoct) to be ...
Altuvoct (efanesoctocog alfa) was approved in the U.K. as a treatment for patients with moderate or severe hemophilia A ages ...
Alnylam awaits FDA decisions on Amvuttra & Fitusiran next month, poised to boost revenue, profitability, and share growth.
Commissioner Sargodha Division Jahanzeb Awan visited the Thalassemia and Hemophilia Centre at Hilal-e-Ahmer Hospital to review the ...
Four years after receiving Hemgenix in a Phase 3 trial, bleeding rates and the use of replacement therapy are low for men ...
Single-Dose Gene Therapy Is Potentially Life-Changing for Adults With Hemophilia B Sep. 25 ... 2024 — A new gene therapy treatment for Duchenne muscular dystrophy (DMD) shows promise of not ...
According to research presented at the EAHAD 2024 Annual Congress, a new classification system enhances diagnosis and ...